← Back to Clinical Trials
Recruiting NCT04688190
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
Trial Parameters
Condition Mitral Regurgitation
Sponsor Universitätsklinikum Hamburg-Eppendorf
Study Type OBSERVATIONAL
Phase N/A
Enrollment 800
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2020-11-01
Completion 2025-03-01
Brief Summary
This multinational, investigator-initiated, retrospective study aims to investigate outcomes of patients, who underwent transcatheter mitral valve implantation (TMVI), in comparison to those screened for TMVI but deemed ineligible, who subsequently underwent interventional mitral valve edge-to-edge repair, mitral valve surgery or medical/conservative therapy.
Eligibility Criteria
Inclusion Criteria: * clinically significant mitral insufficiency * patient underwent screening for TMVI * echocardiography data at baseline (and after TMVI, E2E and surgery) * follow-up of at least 30 days Exclusion Criteria: \- age under 18 years